Pre-market on 05 Mar 2026, CICN.SW stock trades at CHF158.50, up 1.28% from the previous close. Cicor Technologies Ltd. (CICN.SW) on the SIX exchange is drawing attention ahead of an earnings release on 11 Mar 2026 as investors watch its exposure to industrial and medical electronics tied to AI hardware demand. The move follows a 50-day average of CHF136.84 and a 200-day average of CHF164.25, suggesting near-term strength but longer-term resistance around the 200-day mean. We examine fundamentals, technicals, Meyka AI grading, and a model forecast to frame the next tradeable levels for CICN.SW stock.

CICN.SW stock: Price action and near-term drivers

Pre-market price is CHF158.50, a CHF2.00 rise from yesterday. Volume is light at 8,822.00 shares versus an average of 21,708.00, so moves may amplify at the open.

The upcoming earnings announcement on 11 Mar 2026 and demand from aerospace, medical and AI electronics customers are the immediate catalysts for trading in CICN.SW stock.

CICN.SW stock: Fundamental snapshot and valuation

Cicor reports EPS CHF5.29 and a reported PE of 29.96 on the current price of CHF158.50. Market capitalization stands at CHF691,578,771.00, with 4,363,273.00 shares outstanding.

Key ratios include price/50-day average CHF136.84 and price/200-day average CHF164.25, plus a book value per share of CHF33.21 and PB ratio near 4.77. These metrics indicate premium valuation versus book but continued revenue and EBIT growth in FY2024.

CICN.SW stock: Technical context and sector comparison

Technical indicators show RSI 58.30 and ADX 36.15, signalling a firm trend but not overbought conditions. Bollinger upper band sits at CHF179.88, suggesting upside room if momentum resumes.

In the Switzerland Technology sector, average PE is 29.04, so CICN.SW stock’s valuation is roughly in line with peers on price multiples while its ROE at 9.84% trails top sector performers.

CICN.SW stock: Meyka AI grade and forecast

Meyka AI rates CICN.SW with a score out of 100: 77.07 which maps to B+ (BUY). This grade factors in S&P 500 comparison, sector performance, financial growth, key metrics, and analyst inputs.

Meyka AI’s forecast model projects a yearly price of CHF216.23, implying +36.42% from the current CHF158.50. Forecasts are model-based projections and not guarantees.

CICN.SW stock: Risks and AI-related opportunities

Opportunities include rising demand for advanced microelectronics in medical and AI hardware, plus margin improvement from higher-value substrate sales. Recent growth metrics show revenue growth of 23.33% in FY2024.

Risks include inventory cycles (days of inventory on hand 502.99) and interest coverage near 1.05, which increase sensitivity to demand swings and cost inflation for CICN.SW stock.

Final Thoughts

Key takeaways for CICN.SW stock: the pre-market price of CHF158.50 on 05 Mar 2026 reflects measured buying ahead of earnings on 11 Mar 2026 and the stock’s exposure to AI-driven electronics demand. Fundamentals show solid EPS of CHF5.29 and growth, but valuation metrics such as PB 4.77 and PE near 29.96 require earnings upside to justify higher multiples. Meyka AI’s forecast model projects a yearly target of CHF216.23, an implied upside of 36.42% versus the current price; this provides a base-case target alongside a conservative near-term target of CHF180.00 and a bullish three-year target of CHF351.50. Remember that forecasts are projections, not guarantees. Monitor volume at the open, the upcoming earnings report, and any order-book shifts tied to AI supply contracts. For a quick company reference, see Cicor’s investor pages and the CICN.SW stock profile on Meyka’s platform for live updates and tools. Cicor Investors CICN.SW on Meyka

FAQs

Disclaimer:

Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.